NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Frontier Bio

Frontier Bio

Private
Hayward, CaliforniaHealthcare & Life Scienceshttps://www.frontierbio.com/

Last Round

Crowdfunding

Mar 4, 2026

Total Funding Raised

$1.62M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Frontier Bio is a biotechnology company that develops lab-grown human tissues and vascular grafts to provide an alternative to animal testing and address the organ transplant shortage.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

tissue engineeringregenerative medicinevascularized tissuebioprintingbiofabricationcontract researchpreclinical testingin vitro modelsbioresorbable vascular graftsorgan on a chipbiomaterialsdrug discoveryCROlab grown tissuevascular research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Frontier Bio Comps

Public and private peers based on sector, stage, and business model.

Frontier Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Frontier Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingMar 4, 2026
SeedAug 29, 2025
AcceleratorMay 1, 2025
GrantAug 15, 2021
SeedMay 14, 2020
Accelerator
May 2, 2019

Key People

Founding team and executive leadership

Sam Pashneh-Tala

Chief Technology Officer

Executive Team

Frontier Bio Investors

Notable investors and investment history

Frontier Bio investors
InvestorRounds
StartXSeed
BrincAccelerator
Boutique Venture PartnersSeed
Break Off CapitalSeed
America's Seed FundGrant
Alchemist AcceleratorSeed, Accelerator
Immortal DragonsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    Won 'Best Paper' award at the 50th Annual VESS meeting.

  • Apr 9, 2026

    Received Best Paper Award at the VESS Annual Meeting.

Frontier Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Frontier Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Frontier Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersHayward, California
Employee Range10
Year Founded2018
Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.